Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CD93 is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. Additionally we are shipping CD93 Proteins (16) and CD93 Kits (15) and many more products for this protein.
Showing 10 out of 76 products:
Chemical Monoclonal CD93 Primary Antibody for IF - ABIN2658294
Li, Wasserman, Hayakawa, Hardy: Identification of the earliest B lineage stage in mouse bone marrow. in Immunity 1997
Show all 9 references for ABIN2658294
Chemical Monoclonal CD93 Primary Antibody for FACS, WB - ABIN2663652
Norsworthy, Fossati-Jimack, Cortes-Hernandez, Taylor, Bygrave, Thompson, Nourshargh, Walport, Botto: Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis. in Journal of immunology (Baltimore, Md. : 1950) 2004
Show all 7 references for ABIN2663652
Chemical Monoclonal CD93 Primary Antibody for ELISA (Capture), CyTOF - ABIN2661864
Szilvassy, Cory: Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil-treated murine marrow. in Blood 1993
Show all 7 references for ABIN2661864
Human Monoclonal CD93 Primary Antibody for FACS, IP - ABIN967346
Danet, Luongo, Butler, Lu, Tenner, Simon, Bonnet: C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. in Proceedings of the National Academy of Sciences of the United States of America 2002
Show all 7 references for ABIN967346
Human Monoclonal CD93 Primary Antibody for IHC (fro), FACS - ABIN1449221
Ikewaki, Tamauchi, Inoko: Decrease in CD93 (C1qRp) expression in a human monocyte-like cell line (U937) treated with various apoptosis-inducing chemical substances. in Microbiology and immunology 2007
Show all 4 references for ABIN1449221
Human Monoclonal CD93 Primary Antibody for FACS - ABIN2661154
Nepomuceno, Tenner: C1qRP, the C1q receptor that enhances phagocytosis, is detected specifically in human cells of myeloid lineage, endothelial cells, and platelets. in Journal of immunology (Baltimore, Md. : 1950) 1998
Show all 2 references for ABIN2661154
Human Monoclonal CD93 Primary Antibody for ICC, FACS - ABIN1724908
Ikewaki, Yamao, Kulski, Inoko: Flow cytometric identification of CD93 expression on naive T lymphocytes (CD4(+)CD45RA (+) cells) in human neonatal umbilical cord blood. in Journal of clinical immunology 2010
Show all 2 references for ABIN1724908
Human Monoclonal CD93 Primary Antibody for IHC, ELISA - ABIN1724906
Kao, Jiang, Pan, Wang, Chen, Wei, Chen, Chang, Shi, Wu: The epidermal growth factor-like domain of CD93 is a potent angiogenic factor. in PLoS ONE 2012
Show all 2 references for ABIN1724906
Mouse (Murine) Monoclonal CD93 Primary Antibody for FACS, ICC - ABIN4899761
Greenlee-Wacker, Briseño, Galvan, Moriel, Velázquez, Bohlson: Membrane-associated CD93 regulates leukocyte migration and C1q-hemolytic activity during murine peritonitis. in Journal of immunology (Baltimore, Md. : 1950) 2011
soluble EGF (show EGF Antibodies)-like domain containing CD93 protein is a novel angiogenic factor (show VEGFA Antibodies) acting on the endothelium
[review] CD93 regulates inflammation as demonstrated in a murine model of cerebral ischemia reperfusion-induced injury and peritonitis; recent data suggests that a soluble form of CD93 regulates the inflammatory function of monocytes/ macrophages.
these data suggest that cell-associated CD93 regulates leukocyte recruitment and complement activation during murine peritonitis.
we speculate that CD93-neuroprotection is mediated via suppression of the neuroinflammatory response through downregulation of CCL21 (show CCL21 Antibodies).
Cd93 may be an autoimmune susceptibility gene residing within the Idd13 locus, which plays a role in regulating absolute numbers of CD4 (show CD4 Antibodies)(+) NKT (show CTSL1 Antibodies) cells.
Data demonstrate that inflammation triggers release of sCD93 in vivo, identify the inflammatory macrophage as a source of sCD93, and provide insight into the mechanism by which CD93 contributes to engulfment of apoptotic cells.
Impaired uptake of apoptotic cells in C1qRp-deficient mice indicates that the C1qRp receptor may contribute to the removal of dying cells in vivo.
CD93-deficient mice were unable to maintain antibody secretion and bone-marrow plasma-cell numbers, demonstrating that CD93 is important for the maintenance of plasma cells in bone marrow niches.
These data suggest that AA4.1 is a cell surface marker that can identify the earliest lymphohematopoietic progenitors in mouse development.
Data show that CD93 antigen proved to be phosphorylated on tyrosine 628 and 644 following cell adhesion on laminin through dystroglycan (show DAG1 Antibodies).
CD93 expression identifies a predominantly cycling, non-quiescent leukemia-initiating cell population in MLL (show MLL Antibodies)-rearranged AML (show RUNX1 Antibodies), providing opportunities for selective targeting and eradication of LSCs.
The T/T genotype of SNP rs2749817 of CD93 is associated with disseminated cancer.
CD93 is a key regulator of glioma angiogenesis and vascular function, acting via cytoskeletal rearrangements required for cell-cell and cell-matrix adhesion.
These data support a mechanism whereby gC1qR (show C1QBP Antibodies) plays an important role in HPV-16 E2-induced human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathway.
The data indicate that gC1qR (show C1QBP Antibodies) inhibits viability, migration and proliferation of cervical squamous cells carcinoma via the p38 MAPK (show MAPK14 Antibodies) signalling pathway.
Antibody-dependent enhancement of parvovirus B19 involves an alternative mechanism mediated by the heat-sensitive complement factor C1q and its receptor, CD93.
Expression of CD93 on the lymphocyte population of peripheral blood cells from infants at 1 month after birth was also significantly decreased, compared with that for neonatal umbilical cord blood.
HPV 16 E2 induces apoptosis by silencing the gC1qR (show C1QBP Antibodies) gene or inhibiting p38 MAPK (show MAPK14 Antibodies)/JNK (show MAPK8 Antibodies) signalling in cervical squamous cell carcinoma
These data support a mechanism whereby gC1qR (show C1QBP Antibodies) induces apoptosis through the mitochondrial and p53 (show TP53 Antibodies)-dependent pathways in cervical squamous cell carcinoma.
The protein encoded by this gene is a cell-surface glycoprotein and type I membrane protein that was originally identified as a myeloid cell-specific marker. The encoded protein was once thought to be a receptor for C1q, but now is thought to instead be involved in intercellular adhesion and in the clearance of apoptotic cells. The intracellular cytoplasmic tail of this protein has been found to interact with moesin, a protein known to play a role in linking transmembrane proteins to the cytoskeleton and in the remodelling of the cytoskeleton.
, cell surface antigen AA4
, complement component 1 q subcomponent receptor 1
, complement component 1, q subcomponent, receptor 1
, complement component C1q receptor
, lymphocyte antigen 68
, C1q receptor 1
, CD93 antigen
, matrix-remodeling-associated protein 4
, matrix-remodelling associated 4